scholarly article | Q13442814 |
P50 | author | Nancy Hessol | Q91058762 |
P2093 | author name string | Peter Bacchetti | |
Susan Scheer | |||
Sandra Schwarcz | |||
Sharon Pipkin | |||
Rosemary D Cress | |||
P433 | issue | 10 | |
P407 | language of work or name | English | Q1860 |
P304 | page(s) | 1143-1153 | |
P577 | publication date | 2007-03-06 | |
P1433 | published in | American Journal of Epidemiology | Q4744243 |
P1476 | title | The impact of highly active antiretroviral therapy on non-AIDS-defining cancers among adults with AIDS. | |
P478 | volume | 165 |
Q34612071 | A meta-analysis of the incidence of non-AIDS cancers in HIV-infected individuals |
Q40308150 | Anal Cancer Screening in an Urban HIV Clinic: Provider Perceptions and Practice. |
Q28650872 | Anal cancer and intraepithelial neoplasia: epidemiology, screening and prevention of a sexually transmitted disease |
Q36841135 | Anal cancer screening behaviors and intentions in men who have sex with men. |
Q37037858 | Anal intraepithelial neoplasia in a multisite study of HIV-infected and high-risk HIV-uninfected women |
Q88874141 | Are Non-HIV Malignancies Increased in the HIV-Infected Population? |
Q35858493 | Association between Time on Protease Inhibitors and the Incidence of Squamous Cell Carcinoma of the Anus among U.S. Male Veterans |
Q89936584 | Association of antiretroviral therapy with anal high-risk human papillomavirus, anal intraepithelial neoplasia, and anal cancer in people living with HIV: a systematic review and meta-analysis |
Q35801613 | Cancer in HIV-infected persons from the Caribbean, Central and South America |
Q34348772 | Cancer incidence in the multicenter AIDS Cohort Study before and during the HAART era: 1984 to 2007 |
Q37515370 | Cancer risk in HIV-infected persons: influence of CD4(+) count |
Q34481581 | Cancers in the TREAT Asia HIV Observational Database (TAHOD): a retrospective analysis of risk factors |
Q45365429 | Characteristics of colorectal cancer in the human immunodeficiency virus-infected African American population |
Q34774173 | Characteristics of non-AIDS-defining malignancies in the HAART era: a clinico-epidemiological study |
Q40252554 | Clinical presentation and outcomes of prostate cancer in an urban cohort of predominantly African American, human immunodeficiency virus-infected patients |
Q90504869 | Clinico-pathological characteristics among South African women with breast cancer receiving anti-retroviral therapy for HIV |
Q38984209 | Combination antiretroviral therapy and cancer risk |
Q90064836 | Different methods of cell quantification can lead to different results: a comparison of digital methods using a pilot study of dendritic cells in HIV-positive patients |
Q35596183 | Direct benefit of vaccinating boys along with girls against oncogenic human papillomavirus: bayesian evidence synthesis |
Q37233212 | Do antiretrovirals reduce the risk of non-AIDS-defining malignancies? |
Q42538517 | Does HIV/AIDS have a biological impact on the risk of human papillomavirus-related cancers? |
Q28757222 | Early impact and performance characteristics of an established anal dysplasia screening program: program evaluation considerations |
Q35009761 | Effect of immune reconstitution on the incidence of HIV-related Hodgkin lymphoma |
Q33647741 | Effect of reduced immunosuppression after kidney transplant failure on risk of cancer: population based retrospective cohort study |
Q39953766 | End-of-life care for HIV-infected patients with malignancies: A questionnaire-based survey. |
Q27000028 | Epidemic of lung cancer in patients with HIV infection |
Q37727385 | Epidemiological surveillance of the HIV/AIDS complex through the analysis of trends in the incidence of Kaposi's sarcoma in Cali, Colombia |
Q37353390 | Evolving spectrum and incidence of non-AIDS-defining malignancies |
Q36036666 | Exposure to antiretroviral therapy and risk of cancer in HIV-infected persons |
Q37666176 | Factors associated with survival among patients with AIDS-related primary central nervous system lymphoma |
Q37712406 | Factors contributing to risk for cancer among HIV-infected individuals, and evidence that earlier combination antiretroviral therapy will alter this risk |
Q40892448 | German-Austrian guidelines on anal dysplasia and anal cancer in HIV-positive individuals: prevention, diagnosis, and treatment |
Q37246654 | HIV and prostate cancer: a systematic review of the literature |
Q33827510 | HIV infection and the risk of cancers with and without a known infectious cause |
Q35095062 | HIV infection in the etiology of lung cancer: confounding, causality, and consequences |
Q36659641 | HIV infection status, immunodeficiency, and the incidence of non-melanoma skin cancer |
Q37441664 | Human immunodeficiency virus and cancer. A population of HIV-infected patients at Hospital de Santa Maria and predictors of cancer |
Q44667547 | Human immunodeficiency virus-associated prostate cancer: clinicopathological findings and outcome in a multi-institutional study |
Q37176664 | Human papillomavirus and anal neoplasia |
Q33425662 | Human papillomavirus-related disease in people with HIV |
Q46755221 | Imiquimod leads to a decrease of human papillomavirus DNA and to a sustained clearance of anal intraepithelial neoplasia in HIV-infected men. |
Q41055543 | Incidence and Predictors of Abnormal Anal Cytology Findings Among HIV-Infected Adults Receiving Contemporary Antiretroviral Therapy |
Q37710115 | Incidence and epidemiology of anal cancer in the multicenter AIDS cohort study |
Q38124683 | Incidence and risk of lung cancer in HIV-infected patients |
Q41990454 | Incidence of cancer and overall risk of mortality in individuals treated with raltegravir-based and non-raltegravir-based combination antiretroviral therapy regimens |
Q57460856 | Increased risk of anal squamous cell carcinoma in HIV-positive men with prior HBV infection |
Q34535134 | Increased risk of stomach and esophageal malignancies in people with AIDS. |
Q43897862 | Infectious complications of cancer chemotherapy in HIV patients |
Q41922099 | Intracranial Meningioma in patients younger than 35 years of age: An evolution of the disease in the Era of Human Immunodeficiency Virus infection. A retrospective observational study |
Q40045262 | Intracranial Meningiomas in the Era of Human Immunodeficiency Virus Infection and Antiretroviral Therapies in KwaZulu-Natal, South Africa: An Observational Case-Control Study |
Q37794674 | Lung Cancer in HIV-Positive Patients |
Q35688460 | Lung cancer incidence and survival among HIV-infected and uninfected women and men. |
Q35850380 | Malignancies in HIV/AIDS: from epidemiology to therapeutic challenges |
Q37737548 | Management of prostate cancer in HIV-positive patients |
Q39036045 | Morphometric analysis of dendritic cells from anal mucosa of HIV-positive patients and the relation to intraepithelial lesions and cancer seen at a tertiary health institution in Brazil |
Q35233148 | Mortality after cancer diagnosis in HIV-infected individuals treated with antiretroviral therapy |
Q41067770 | Neurological complications of HIV infection in pre-HAART and HAART era: a retrospective study |
Q35012513 | Non-AIDS defining cancers in the D:A:D Study--time trends and predictors of survival: a cohort study |
Q37838813 | Non-AIDS-Defining Malignancies in Patients with HIV in the HAART Era. |
Q38084785 | Non-AIDS-defining cancers in New Orleans |
Q37216892 | Non-AIDS-defining malignancies among HIV-infected patients in the highly active antiretroviral therapy era. |
Q37180845 | Non-AIDS-defining malignancies in HIV-infected persons: etiologic puzzles, epidemiologic perils, prevention opportunities |
Q34157953 | Noncommunicable diseases in HIV infection in low- and middle-income countries: gastrointestinal, hepatic, and nutritional aspects |
Q43571985 | Oral squamous cell carcinoma in human immunodeficiency virus positive patients: clinicopathological audit |
Q34604639 | Pattern of cancer risk in persons with AIDS in Italy in the HAART era. |
Q34110884 | Plasma biomarkers for detecting Hodgkin's lymphoma in HIV patients. |
Q42097140 | Plasmablastic lymphoma of gingiva mimicking a reactive lesion: a case report |
Q35850196 | Premalignant lesions of the anal canal and squamous cell carcinoma of the anal canal |
Q92126108 | Prostate cancer in sexual minorities and the influence of HIV status |
Q40223990 | Racial differences in prostate cancer risk in young HIV-positive and HIV-negative men: a prospective cohort study |
Q37272349 | Risk factors for anal HPV infection and anal precancer in HIV-infected men who have sex with men |
Q37038493 | Risk factors for anal human papillomavirus infection type 16 among HIV-positive men who have sex with men in San Francisco |
Q34635523 | Risk of anal cancer in HIV-infected and HIV-uninfected individuals in North America |
Q37309962 | Risk of human papillomavirus-associated cancers among persons with AIDS. |
Q35150769 | Risk of melanoma in people with HIV/AIDS in the pre- and post-HAART eras: a systematic review and meta-analysis of cohort studies. |
Q37439906 | Screening HIV-infected patients for non-AIDS-defining malignancies |
Q34064264 | Spectrum of cancer risk late after AIDS onset in the United States. |
Q36243929 | The Spectrum of Malignancies among Adult HIV Cohort in Poland between 1995 and 2012: A Retrospective Analysis of 288 Cases |
Q34952990 | The effect of HAART and calendar period on Kaposi's sarcoma and non-Hodgkin lymphoma: results of a match between an AIDS and cancer registry |
Q26861496 | The rising challenge of non-AIDS-defining cancers in HIV-infected patients |
Q43663092 | Tolerance and toxicity of primary radiation therapy in the management of seropositive HIV patients with squamous cell carcinoma of the head and neck |
Q40259517 | Trends in cancer diagnoses and survival among persons with AIDS in a high HIV prevalence urban area |
Q60919768 | Trends in mortality among ART-treated HIV-infected adults in the Asia-Pacific region between 1999 and 2017: results from the TREAT Asia HIV Observational Database (TAHOD) and Australian HIV Observational Database (AHOD) of IeDEA Asia-Pacific |
Q38414729 | Trends in survival after cancer diagnosis among HIV-infected individuals between 1992 and 2009. Results from the FHDH-ANRS CO4 cohort |
Q37305792 | Trends in the incidence of cancers among HIV-infected persons and the impact of antiretroviral therapy: a 20-year cohort study |
Q35950097 | Trends in the occurrence of high-grade anal intraepithelial neoplasia in San Francisco: 2000-2009. |
Q58006066 | What Drives the Number of High-Risk Human Papillomavirus Types in the Anal Canal in HIV-Positive Men Who Have Sex With Men? |
Q64894223 | [Anal intraepithelial neoplasia and anal carcinoma: an increasing problem in HIV patients]. |